01:36 PM EST - AnorMED : Genzyme Corp. announced Tuesday it has boosted its hostile offer for Vancouver-based AnorMED by 58 percent to $13.50 US a share. The new all-cash offer tops the $12 US-a-share friendly bid from Millennium Pharmaceuticals made on Sept, 26, which handily topped Genzyme's opening bid of $8.55 US a share. AnorMED
T.AOM are trading up 85 cents at $15.90.
